277 related articles for article (PubMed ID: 28577764)
1. Effectiveness and Cost-Effectiveness of Endoscopic Screening and Surveillance.
Saxena N; Inadomi JM
Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):397-421. PubMed ID: 28577764
[TBL] [Abstract][Full Text] [Related]
2. Who Deserves Endoscopic Screening for Esophageal Neoplasia?
Blevins CH; Iyer PG
Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):365-378. PubMed ID: 28577762
[TBL] [Abstract][Full Text] [Related]
3. Screening and Surveillance for Barrett's Esophagus: Is It Cost-Effective?
Inadomi JM; Saxena N
Dig Dis Sci; 2018 Aug; 63(8):2094-2104. PubMed ID: 29948571
[TBL] [Abstract][Full Text] [Related]
4. Screening for Barrett's esophagus.
Spechler SJ
Rev Gastroenterol Disord; 2002; 2 Suppl 2():S25-9. PubMed ID: 12478241
[TBL] [Abstract][Full Text] [Related]
5. Screening and surveillance in Barrett's esophagus: a call to action.
Eisen GM; Lieberman D; Fennerty MB; Sonnenberg A
Clin Gastroenterol Hepatol; 2004 Oct; 2(10):861-4. PubMed ID: 15476148
[No Abstract] [Full Text] [Related]
6. Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges.
Kamboj AK; Katzka DA; Iyer PG
Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):27-41. PubMed ID: 33213798
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer.
Streitz JM; Ellis FH; Tilden RL; Erickson RV
Am J Gastroenterol; 1998 Jun; 93(6):911-5. PubMed ID: 9647017
[TBL] [Abstract][Full Text] [Related]
8. How to get the most out of costly Barrett's oesophagus surveillance.
Braden B; Jones-Morris E
Dig Liver Dis; 2018 Sep; 50(9):871-877. PubMed ID: 29730158
[TBL] [Abstract][Full Text] [Related]
9. Should we screen patients for Barrett's esophagus? Yes: men with long-standing reflux symptoms should be screened with endoscopy.
Strayer SM
Am Fam Physician; 2011 May; 83(10):1140, 1142, 1147. PubMed ID: 21568246
[No Abstract] [Full Text] [Related]
10. Barrett's oesophagus: Current controversies.
Amadi C; Gatenby P
World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness Analysis on Endoscopic Surveillance Among Western Patients With Barrett's Esophagus for Esophageal Adenocarcinoma Screening.
Yang Y; Chen HN; Wang R; Tang YJ; Chen XZ
Medicine (Baltimore); 2015 Sep; 94(39):e1105. PubMed ID: 26426603
[TBL] [Abstract][Full Text] [Related]
12. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
Shaheen N; Ransohoff DF
JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease.
Gerson LB; Groeneveld PW; Triadafilopoulos G
Clin Gastroenterol Hepatol; 2004 Oct; 2(10):868-79. PubMed ID: 15476150
[TBL] [Abstract][Full Text] [Related]
14. Esophageal adenocarcinoma in a first-degree relative increases risk for esophageal adenocarcinoma in patients with Barrett's esophagus.
Tofani CJ; Gandhi K; Spataro J; Yoo J; Murphy M; Mohan N; Daitch Z; Shah A; Janowski R; Huntley C; Dabbish N; Keith S; Coben R; Cohen S; Kastenberg D; Infantolino A
United European Gastroenterol J; 2019 Mar; 7(2):225-229. PubMed ID: 31080607
[TBL] [Abstract][Full Text] [Related]
15. Esophageal adenocarcinoma and Barrett's esophagus.
Sayana H; Wani S; Sharma P
Minerva Gastroenterol Dietol; 2007 Jun; 53(2):157-69. PubMed ID: 17557044
[TBL] [Abstract][Full Text] [Related]
16. The wizards of odds: cost-effectiveness, Barrett's screening, and surveillance guidelines.
Perdue DG; Murray J; Wang KK
Clin Gastroenterol Hepatol; 2004 Oct; 2(10):865-7. PubMed ID: 15476149
[No Abstract] [Full Text] [Related]
17. [Screening for adenocarcinoma in Barrett's esophagus: yes or no, when and how?].
Sostres C; Lacarta P; Lanas A
Gastroenterol Hepatol; 2013 Oct; 36(8):520-6. PubMed ID: 23453559
[TBL] [Abstract][Full Text] [Related]
18. How far to go? Screening and surveillance in Barrett's esophagus.
Lieberman DA; Sampliner RE
Am J Manag Care; 2001 Feb; 7(1 Suppl):S19-26. PubMed ID: 11225349
[TBL] [Abstract][Full Text] [Related]
19. [Barrett's esophagus. Prevalence, risk of adenocarcinoma, role of endoscopic surveillance].
Zaninotto G; Costantini M; Molena D; Rizzetto C; Ekser B; Ancona E
Minerva Chir; 2002 Dec; 57(6):819-36. PubMed ID: 12592224
[TBL] [Abstract][Full Text] [Related]
20. Barrett's esophagus: is it all that bad?
Tytgat GN
Can J Gastroenterol; 1999 Jun; 13(5):385-8. PubMed ID: 10377467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]